The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Debates at COMy 2022: MRD, immune therapies, and more
In this video, Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, highlights the interesting debates that will be held at the 8th World Congress on Controversies in Multiple Myeloma (COMy), virtually and in Paris, France, from May 12 – 14, 2022. Debates will be held on many important topics within myeloma treatment, including measurable residual disease (MRD)-guided therapy, the replacement of transplantation with immune therapies, and more.
